The frequency of Th17 and Th22 cells in patients with colorectal cancer at pre-operation and post-operation

References

• Bronte V. (2008). Th17 and cancer: Friends or foes? Blood, 112, 214--4
   Google Scholar
• Chang LY, Lin YC, Mahalingam J, et al. (2012). Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res, 72, 1092–102
   PubMed Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. (2006). Paradoxical roles of the immune system during cancer development. Nat Rev Cancer, 6, 24–37
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Andreu P, Coussens LM. (2010). Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev, 29, 309–16
   PubMed Web of Science ®Google Scholar
• Eyerich S, Eyerich K, Pennino D, et al. (2009). Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest, 119, 3573–85
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Wang K, Mucida D, et al. (2012). Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature, 491, 254–8
   PubMed Web of Science ®Google Scholar
• Huang C, Fu ZX. Localization of IL-17+Foxp3+ T cells in esophageal cancer. Immunol Invest, 2011, 40, 400–12
   Google Scholar
• Huber S, Gagliani N, Zenewicz LA, et al. (2012). IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature, 491, 259–63
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin, 61, 69–90
   PubMed Web of Science ®Google Scholar
• Jiang R, Wang H, Deng L, et al. (2013). IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer, 13, 59
   PubMed Web of Science ®Google Scholar
• Kanai T, Mikami Y, Sujino T, et al. (2012). RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation. Mucosal Immunol, 5, 240–7
   Google Scholar
• Kerscher AG, Chua TC, Gasser M, et al. (2013). Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: A longitudinal experience of 2406 patients over two decades. Br J Cancer, 108, 1432–9
   Google Scholar
• Kirchberger S, Royston DJ, Boulard O, et al. (2013). Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med, 210, 917–31
   PubMed Web of Science ®Google Scholar
• Kryczek I, Banerjee M, Cheng P, et al. (2009). Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood, 114, 1141–9
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wu K, Zhao E, et al. (2011). IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol, 186, 4388–95
   PubMed Web of Science ®Google Scholar
• Liu T, Peng L, Yu P, et al. (2012). Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. J Clin Immunol, 32, 1332–9
   PubMed Web of Science ®Google Scholar
• Muranski P, Restifo NP. (2009). Does IL-17 promote tumor growth? Blood, 114, 231–2
   Google Scholar
• Sellitto A, Galizia G, De Fanis U, et al. (2011). Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery. J Clin Immunol, 31, 1095–104
   Google Scholar
• Sergei I, Greten FR, Karin M. (2010). Immunity, inflammation, and cancer. Cell, 140, 883–99
   Google Scholar
• Seshagiri S. (2013). The burden of faulty proofreading in colon cancer. Nat Genet, 45, 121–2
   Google Scholar
• Siakavellas SI, Bamias G. (2012). Role of the IL-23/IL-17 axis in Crohn's disease. Discov Med, 14, 253–62
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K, et al. (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 62, 220–41
   PubMed Web of Science ®Google Scholar
• Sobhani I, Tap J, Roudot-Thoraval F, et al. (2011). Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 6, e16393
   PubMed Web of Science ®Google Scholar
• Stolfi C, Rizzo A, Franzè E, et al. (2011). Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med, 208, 2279–90
   Google Scholar
• Su X, Ye J, Hsueh EC, et al. (2010). Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol, 184, 1630–41
   PubMed Web of Science ®Google Scholar
• Thompson CL, Plummer SJ, Tucker TC, et al. (2010). Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Cont, 21, 1165–70
   PubMed Web of Science ®Google Scholar
• Trifari S, Kaplan CD, Tran EH, et al. (2009). Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nat Immunol, 10, 864–71
   PubMed Web of Science ®Google Scholar
• Ustyugova IV, Zhi L, Abramowitz J, et al. (2012). IEX-1 deficiency protects against colonic cancer. Mol Cancer Res, 10, 760–7
   PubMed Web of Science ®Google Scholar
• Wang J, Xu K, Wu J, et al. (2012). The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers. BMC Cancer, 12, 418
   Google Scholar
• Weber GF, Gaertner FC, Erl W, et al. (2006). IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase. J Immunol, 177, 8266–72
   PubMed Web of Science ®Google Scholar
• Whiteside TL. (2006). Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol, 16, 3–15
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Witte E, et al. (2004). IL-22 increases the innate immunity of tissues. Immunity, 21, 241–54
   PubMed Web of Science ®Google Scholar
• Yang S, Wang B, Guan C, et al. (2011). Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol, 89, 85–91
   PubMed Web of Science ®Google Scholar
• Zbar AP. (2004). The immunology of colorectal cancer. Surg Oncol, 13, 45–53
   Google Scholar